» Articles » PMID: 38163844

Hypoxia Induces Mitochondrial Protein Lactylation to Limit Oxidative Phosphorylation

Overview
Journal Cell Res
Specialty Cell Biology
Date 2024 Jan 1
PMID 38163844
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative phosphorylation (OXPHOS) consumes oxygen to produce ATP. However, the mechanism that balances OXPHOS activity and intracellular oxygen availability remains elusive. Here, we report that mitochondrial protein lactylation is induced by intracellular hypoxia to constrain OXPHOS. We show that mitochondrial alanyl-tRNA synthetase (AARS2) is a protein lysine lactyltransferase, whose proteasomal degradation is enhanced by proline 377 hydroxylation catalyzed by the oxygen-sensing hydroxylase PHD2. Hypoxia induces AARS2 accumulation to lactylate PDHA1 lysine 336 in the pyruvate dehydrogenase complex and carnitine palmitoyltransferase 2 (CPT2) lysine 457/8, inactivating both enzymes and inhibiting OXPHOS by limiting acetyl-CoA influx from pyruvate and fatty acid oxidation, respectively. PDHA1 and CPT2 lactylation can be reversed by SIRT3 to activate OXPHOS. In mouse muscle cells, lactylation is induced by lactate oxidation-induced intracellular hypoxia during exercise to constrain high-intensity endurance running exhaustion time, which can be increased or decreased by decreasing or increasing lactylation levels, respectively. Our results reveal that mitochondrial protein lactylation integrates intracellular hypoxia and lactate signals to regulate OXPHOS.

Citing Articles

Lactylation: a promising therapeutic target in ischemia-reperfusion injury management.

Wang F, Mu G, Yu Z, Shi Z, Li X, Fan X Cell Death Discov. 2025; 11(1):100.

PMID: 40082399 PMC: 11906755. DOI: 10.1038/s41420-025-02381-4.


Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies.

Lv M, Huang Y, Chen Y, Ding K Exp Hematol Oncol. 2025; 14(1):32.

PMID: 40057816 PMC: 11889934. DOI: 10.1186/s40164-025-00622-x.


Regulatory role and therapeutic prospect of lactate modification in cancer.

Sun M, Wang K, Lu F, Yu D, Liu S Front Pharmacol. 2025; 16:1508552.

PMID: 40034817 PMC: 11872897. DOI: 10.3389/fphar.2025.1508552.


Lactate metabolism and lactylation in kidney diseases: insights into mechanisms and therapeutic opportunities.

Cheng Y, Guo L Ren Fail. 2025; 47(1):2469746.

PMID: 40012230 PMC: 11869332. DOI: 10.1080/0886022X.2025.2469746.


Multi-omics study on the effect of moderate-intensity exercise on protein lactylation in mouse muscle tissue.

Chang J, Wu W, Qian P, Lu Z, He X, Wang F Front Cell Dev Biol. 2025; 12:1472338.

PMID: 39935788 PMC: 11810897. DOI: 10.3389/fcell.2024.1472338.


References
1.
Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

2.
Spriet L, Tunstall R, Watt M, Mehan K, Hargreaves M, Cameron-Smith D . Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting. J Appl Physiol (1985). 2004; 96(6):2082-7. DOI: 10.1152/japplphysiol.01318.2003. View

3.
Carrell E, Coppola A, McBride H, Dirksen R . Orai1 enhances muscle endurance by promoting fatigue-resistant type I fiber content but not through acute store-operated Ca2+ entry. FASEB J. 2016; 30(12):4109-4119. PMC: 5102113. DOI: 10.1096/fj.201600621R. View

4.
Baumann F, Leukel P, Doerfelt A, Beier C, Dettmer K, Oefner P . Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol. 2008; 11(4):368-80. PMC: 2743217. DOI: 10.1215/15228517-2008-106. View

5.
Bassett Jr D, Howley E . Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000; 32(1):70-84. DOI: 10.1097/00005768-200001000-00012. View